[Onasemnogene abeparvovec (spinal muscular atrophy) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
Record ID 32018000831
German
Original Title:
Onasemnogen-Abeparvovec (5q-assoziierte spinale Muskelatrophie) – Bewertung gemäß § 35a Abs. 1 Satz 11 SGB V
Details
Project Status:
Completed
Year Published:
2020
URL for published report:
https://www.iqwig.de/download/G20-12_Onasemnogen-Abeparvovec_Bewertung-35a-Absatz-1-Satz-11-SGB-V_V1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Spinal Muscular Atrophies of Childhood
- Genetic Therapy
- Muscular Atrophy, Spinal
- Infant
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.